SIFI > Manufacturing
Manufacturing
In the last years SIFI has generated more than 60 patents and secured international alliances worldwide to export its growing portfolio overseas. Our product range spans from state-of-the-art intraocular lenses for cataract surgery to nutraceuticals, helping to support the diet in order to prevent the occurrence of retinal pathologies.

Our 60,000 square meter manufacturing plant has a capacity of up to 23 million units a year and is equipped with advanced Blow-Fill-Seal (BFS) technology, allowing the production of ophthalmic products in unit and multi-dose formats. Unit-dose format introduction has allowed to effectively respond to the need for greater drug tolerance and dosage precision. The BFS system also enables production without use of preservatives and accurate calibration of instilled drug quantities.

Focus On > Versatility
Our new manufacturing facility, dedicated to the production of intraocular lenses, is an example of technological excellence. Conceived according to the highest standards, it ensures unrivaled levels of precision and control during all phases of production, for each and every single unit. The result is production of superior quality lenses by means of an extraordinarily flexible process.

The use of robotics during the manufacturing process, together with the adoption of an advanced ERP system for production planning, makes the facility extraordinarily flexible, allowing for constant product innovation.

SIFI Group Manufacturing Plants are certified by TUV Sud (SIFI Medtech) and Certiquality (S.I.F.I. S.p.A) they are compliant with European specific standards, as shown by the CE symbol on our products.

View and download Manufacturing Plant Certifications:

ISO 9001:2008
ISO 13485:2012

Focus On > Advanced Engineering
SIFI diagnostic products owe their competitive advantages to sophisticated engineering and ergonomic qualities, which make them ideally suited to the needs of both physicians and patients.

Manufacturing encompasses optical, electronic, mechanical and software engineering, with added value coming from integration of these technologies into easy-to-use instruments.

share & tag us with
#techtips  #EyeCare #eyeinfo #health #innovation #eye #vision #quality #engineering
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

 
 
Quality We CARE for patients; all patients, even those frequently left behind by the industry, such as individuals afflicted by rare diseases.   SIFI’s 80-year long history is distinguished...
 
General questions info@sifigroup.com   International Markets export@sifigroup.com       Pharmacovigilance pharmacovigilance@sifigroup.com   Vigilance...
 
International Markets In the last years SIFI has undergone a virtuous growth of its business, evolving into an industrial group of companies, consolidating domestic leadership and expanding...

On our Social Channels

From our News Center

Latest news from ophthalmic research as to the developing of an effective and safe treatment for Acanthamoeba Keratitis. At the annual meeting of the Association for Research in Vision and...
 

 

08 June

Degenerative eye diseases are often related to major pathologies diagnosed in advanced stages and they can also result from an incomplete “integrated approach”...
Follow Us!